andamanmedical

Malaysia: Interim Directive on Implantable Device Traceability

The Medical Device Authority (MDA), Malaysia has issued an Interim Directive on Implantable Device Traceability concerning the traceability requirements for implantable medical devices under Subregulation 3(2) of the Medical Device Regulations 2019. While the legal obligation for establishments to maintain traceability records down to the patient level remains in force, the policy is currently under […]

Malaysia: Interim Directive on Implantable Device Traceability Read More »

Malaysia: MDA Revision to Labelling Requirements for Foreign Manufacturer Contact Details

The Medical Device Authority (MDA) has announced a revision to the requirements for foreign manufacturer contact details under the Guidance Document MDA/GD/0026: Requirements for Labelling of Medical Devices. The update forms part of the latest revision to Malaysia’s medical device labelling guidance and applies to both general medical devices and In-Vitro Diagnostic (IVD) medical devices.

Malaysia: MDA Revision to Labelling Requirements for Foreign Manufacturer Contact Details Read More »

Malaysia and China: Joint Evaluation Pilot Programme Phase 2

The Medical Device Authority (MDA) announced the commencement of the Malaysia–China Joint Evaluation Pilot Programme, Pilot Phase 2, from 1 July to 30 September 2026 under the Global Harmonization Working Party (GHWP) Common Evaluation Reliance Practice (CERP) framework. The pilot introduces a Joint Evaluation approach between MDA Malaysia and NMDA / NMPA China, where both

Malaysia and China: Joint Evaluation Pilot Programme Phase 2 Read More »

Malaysia: CAB Conformity Assessment Required for COVID-19 Test Kit Re-Registration

The Medical Device Authority (MDA) wishes to inform all stakeholders that the exemption from the Conformity Assessment Process by a Conformity Assessment Body (CAB) for the registration of COVID-19 Test Kits is no longer applicable following the withdrawal of the relevant circular letter on 23 February 2024. All subsequent registration applications, including applicable re-registration applications

Malaysia: CAB Conformity Assessment Required for COVID-19 Test Kit Re-Registration Read More »

Malaysia and Japan: Strategic MoC to Strengthen Bilateral Medical Device Regulatory Cooperation

The Medical Device Authority (MDA) of Malaysia and the Ministry of Health, Labour and Welfare (MHLW) of Japan signed a Memorandum of Cooperation (MoC) on 10 June 2026 in Tokyo to strengthen regulatory cooperation in the medical device sector. Executed during the official visit of the Prime Minister of Malaysia to Japan, the MoC aims

Malaysia and Japan: Strategic MoC to Strengthen Bilateral Medical Device Regulatory Cooperation Read More »

Malaysia: MDA Strengthens Monitoring of Medical Device Safety in the Market

The Medical Device Authority (MDA) has conducted laboratory testing on six (6) types of medical devices as part of its market surveillance activities. ECRI Berhad was appointed as the testing laboratory to carry out technical and performance evaluations of the identified medical devices based on the descriptions of complaints received. A total of six (6)

Malaysia: MDA Strengthens Monitoring of Medical Device Safety in the Market Read More »

2026 Trend: Expanding Access to Diagnostics Through Point-of-Care and AI Integration

Asia Pacific continues to present strong growth opportunities for the in vitro diagnostics (IVD) market, particularly through the expanding adoption of point-of-care testing (POCT) and AI-driven diagnostic technologies. With large geographical areas and uneven healthcare infrastructure across many countries, improving diagnostic accessibility remains a key priority. Governments and healthcare providers across the region are increasingly

2026 Trend: Expanding Access to Diagnostics Through Point-of-Care and AI Integration Read More »

Philippines: Draft Rules and Regulations on Clinical Investigations of Medical Devices and Clinical Performance Studies of IVD Medical Devices

The Philippine Food and Drug Administration (FDA) has released for public comment a Draft Administrative Order that will establish the rules and requirements for conducting Clinical Investigation (CI) of Medical Devices and Clinical Performance Studies (CPS) of In-Vitro Diagnostic (IVD) Medical Devices in the Philippines. Stakeholders are invited to submit comments on or before 25

Philippines: Draft Rules and Regulations on Clinical Investigations of Medical Devices and Clinical Performance Studies of IVD Medical Devices Read More »

Regulatory Harmonisation: Shaping the Future of Medical Devices in Southeast Asia

In 2025, regulatory harmonisation across Southeast Asia continues to gain momentum, led by the ASEAN Medical Device Directive (AMDD). This initiative is reshaping the region’s medical device landscape by establishing more unified standards that support both patient safety and streamlined market access. Key Trends Driving This Transformation: AMDD in Action The AMDD seeks to align

Regulatory Harmonisation: Shaping the Future of Medical Devices in Southeast Asia Read More »

2026 Trend: Asia Pacific IVD Growth Driven by Precision Diagnostics

Asia Pacific remains a key growth market for in vitro diagnostics, with the regional IVD market estimated at USD 27.01 billion in 2026 and projected to reach USD 35.4 billion by 2031, growing at a 5.54% CAGR. Rising healthcare investment, broader diagnostic access, and an increasing chronic disease burden continue to support steady demand across

2026 Trend: Asia Pacific IVD Growth Driven by Precision Diagnostics Read More »

Thailand: Verification and Validation Guidelines for Alcohol-Containing Products Intended for Disinfecting Purposes for Humans, Animals, and Medical Devices

Following the Ministry of Public Health Notification B.E. 2562 (2019) regarding alcohol-containing products intended for disinfection of humans, animals, and medical devices, the Medical Device Control Division has undertaken a comprehensive review of such products. This review included the issuance of notification certificates and the evaluation of supporting documentation required for regulatory submissions. To ensure

Thailand: Verification and Validation Guidelines for Alcohol-Containing Products Intended for Disinfecting Purposes for Humans, Animals, and Medical Devices Read More »

Philippines: Publication and Filing Details of DOH Administrative Order No. 2025-0030

The Philippines Department of Health has issued Administrative Order (AO) 2025-0030, formally adopting the Post-Marketing Alert System (PMAS) requirements under Annex 5 of the ASEAN Medical Device Directive (AMDD). This AO establishes the mandatory post-market surveillance framework for medical devices in the Philippines, ensuring continued safety, performance, and quality following market authorization. Read more here:

Philippines: Publication and Filing Details of DOH Administrative Order No. 2025-0030 Read More »

Philippines: Guidelines on the Use of the “eSUMBONG” System Within the New FDA Website

The Food and Drug Administration (FDA) has officially launched the eSUMBONG system, a new online reporting mechanism integrated into its updated website. This initiative marks a significant advancement in regulatory enforcement, providing the public with a streamlined and secure channel to lodge complaints or report violations concerning FDA-regulated products. By centralizing complaint submissions, the FDA

Philippines: Guidelines on the Use of the “eSUMBONG” System Within the New FDA Website Read More »

Singapore: Software Medical Devices, IVDs, SAR and Registration Initiatives

The Health Sciences Authority (HSA) has introduced a series of regulatory initiatives aimed at strengthening oversight of medical devices while promoting innovation and timely patient access. The updates cover software and AI-enabled medical devices, dealer licensing requirements, regulatory reliance, IVD reclassification, and Special Access Route (SAR) registration initiatives. Read the full update here:https://www.hsa.gov.sg/announcements/hsa-regulatory-updates-for-medical-devices-and-ivds—virtual-session-on-20-may-2026/ Purpose of

Singapore: Software Medical Devices, IVDs, SAR and Registration Initiatives Read More »

Thailand: Fast Track Emergency Measure for Medical Device Change Notification for Middle East Crisis Management

To mitigate the impact of the crisis situation in the Middle East and support manufacturers and importers of medical devices affected by disruptions in the supply chain of raw materials, packaging, or finished products, the Thai FDA has introduced a Fast Track channel for specific medical device change submissions. This initiative aims to facilitate faster

Thailand: Fast Track Emergency Measure for Medical Device Change Notification for Middle East Crisis Management Read More »

Thailand: Thai FDA Updates Establishment Registration Form

The Thai Food and Drug Administration (FDA) has announced updates to the establishment registration form for the manufacturing, import, and sale of medical devices. This revision enhances regulatory oversight in line with the digital age, aiming to cover new technologies, particularly Standalone Medical Software, while reducing bureaucratic steps for entrepreneurs and ensuring consumers receive clear,

Thailand: Thai FDA Updates Establishment Registration Form Read More »

Thailand: Submission of Power of Attorney in Case of Identity Verification by Document

In cases where identity verification cannot be completed via the Thai ID application as required by the system, the authorizer or the authorized person may instead use the document-based identity verification method. Power of Attorney (POA) to the Thai FDA is to formally authorize a representative, often a local agent or authorized person, to act

Thailand: Submission of Power of Attorney in Case of Identity Verification by Document Read More »

Thailand: Guideline for Manufacturing/Import License Application for Patient-Specific Dental Medical Devices Risk Classification 2–4

The Thai FDA has issued guidelines for the registration of patient-specific dental medical devices under Risk Classification 2–4. The key consideration is that product properties are assessed based on the primary raw materials rather than the finished product. Read the full infographic here: กองควบคุมเครื่องมือแพทย์  (Thai FDA Official Website in Thai). Purpose of the Guideline To

Thailand: Guideline for Manufacturing/Import License Application for Patient-Specific Dental Medical Devices Risk Classification 2–4 Read More »

Thailand: Adjusting the Document Correction Timeframe in Change Submission

In accordance with the new Thai FDA Change Notification guidelines, the Thai FDA has revised the amendment timeframes within the Change Notification System. The updated requirement applies to newly submitted Change Notification applications starting from 20 April 2026. Read the full press release here: กองควบคุมเครื่องมือแพทย์ (Thai FDA Official Website in Thai). Purpose of the Press

Thailand: Adjusting the Document Correction Timeframe in Change Submission Read More »

Indonesia: New Regulation on Health Supplies – MoH Regulation No. 5 Year 2026

The Indonesian Ministry of Health has issued Regulation of the Minister of Health of the Republic of Indonesia No. 5 Year 2026 regarding Health Supplies (Perbekalan Kesehatan). This landmark framework serves as an umbrella regulation governing the comprehensive, end-to-end management of health supplies in Indonesia. Its scope encompasses pharmaceutical products, medical devices, household health products

Indonesia: New Regulation on Health Supplies – MoH Regulation No. 5 Year 2026 Read More »

Andaman Medical Returns to CMEF Shanghai 2026: Supporting MedTech Companies Expanding into Southeast Asia

As more MedTech manufacturers look beyond China and explore Southeast Asia as their next growth market, many are seeking clearer guidance on how to navigate ASEAN regulatory pathways, market access requirements, and local commercial strategies. With this growing demand in mind, Andaman Medical returned to the 93rd China International Medical Equipment Fair (CMEF) in Shanghai

Andaman Medical Returns to CMEF Shanghai 2026: Supporting MedTech Companies Expanding into Southeast Asia Read More »

2026 Trend: Technological Innovation Accelerating IVD Growth in Asia Pacific

Asia Pacific is rapidly becoming one of the most transformative regions for In Vitro Diagnostics (IVD), driven by fast-advancing technologies and growing demand for high-precision, accessible diagnostic solutions. As healthcare systems across the region invest in modernization and digital health, innovation in diagnostics is playing a critical role in reshaping clinical workflows and elevating standards

2026 Trend: Technological Innovation Accelerating IVD Growth in Asia Pacific Read More »

Malaysia: New Guidance for Confirmation of Obsolete and Discontinued Medical Devices

The Medical Device Authority (MDA) of Malaysia has published the First Edition of the Guidance Document on Application for Confirmation Status of Obsolete and Discontinued Medical Devices. This guidance provides clarity on the regulatory pathway for managing obsolete and discontinued medical devices in Malaysia, particularly in situations where such devices may no longer fully comply

Malaysia: New Guidance for Confirmation of Obsolete and Discontinued Medical Devices Read More »

Malaysia: MDA Joins WHO Collaborative Registration Procedure (CRP) for IVDs

The Medical Device Authority (MDA), Ministry of Health Malaysia, has officially joined the WHO Collaborative Registration Procedure (CRP) as a participating National Regulatory Authority (NRA) for WHO-prequalified in vitro diagnostic (IVD) products, effective 3 February 2026. This reliance-based mechanism allows MDA to leverage WHO prequalification assessments to accelerate the national registration process, reduce duplication of

Malaysia: MDA Joins WHO Collaborative Registration Procedure (CRP) for IVDs Read More »

Malaysia: Updated Guidance – Special Access Exemption for Unregistered Medical Devices

The Medical Device Authority (MDA) of Malaysia has released the Third Edition Guidance on special access for unregistered medical devices. This update introduces a more structured and stricter process, replacing the previous notification-based system (including email submissions and Route A/B classification) with a single, mandatory online application via the MeDC@St system. Eligibility is now limited

Malaysia: Updated Guidance – Special Access Exemption for Unregistered Medical Devices Read More »

Vietnam: MoH Requests Industry Feedback to Support Revision of Medical Device Regulations

On 24 March 2026, the Vietnam Ministry of Health (MoH) issued Official Letter No. 1956/BYT-HTTB, requesting organizations involved in the production, registration, importation, and trading of medical devices to submit a report reviewing the implementation of Decree No. 98/2021/NĐ-CP on medical device management. This request supports the development of a revised decree in line with

Vietnam: MoH Requests Industry Feedback to Support Revision of Medical Device Regulations Read More »

Why Global MedTech Leaders Are Increasing Investment in Asia

Asia is rapidly emerging as a strategic hub for innovation, manufacturing, and commercial expansion in the global MedTech landscape. No longer viewed solely as an end market, the region is becoming a core base where leading companies build capabilities to meet diverse and fast-growing healthcare needs. Insights shared from last year’s LSI USA Emerging MedTech

Why Global MedTech Leaders Are Increasing Investment in Asia Read More »

Vietnam: New Decree on Product and Goods Quality Management Issued

On January 23, 2026, the Vietnamese Government issued Decree No. 37/2026/ND-CP, detailing provisions and measures for the implementation of the Law on Product and Goods Quality. The Decree establishes a comprehensive regulatory framework consisting of 8 chapters and 99 articles governing the quality management of products and goods circulating in Vietnam, with a strong emphasis

Vietnam: New Decree on Product and Goods Quality Management Issued Read More »

Malaysia: MDA Launches Innovative Medical Device Review Pathway

On March 9, 2026, the Medical Device Authority (MDA), Ministry of Health Malaysia, announced the implementation of the Innovative Medical Device Review Pathway to support the development and regulatory readiness of innovative medical devices in Malaysia. The initiative aligns with the New Industrial Master Plan (NIMP) 2030 and aims to foster collaboration between government, academia,

Malaysia: MDA Launches Innovative Medical Device Review Pathway Read More »

Philippines: Administrative Order 2025-0030 Implementing Guidelines for the Post-Marketing Alert System (PMAS) Requirements, Annex 5 of the ASEAN Medical Device Directive (AMDD)

Administrative Order (AO) 2025-0030 was issued by the Philippines Department of Health to formally adopt and implement the Post-Marketing Alert System (PMAS) requirements under Annex 5 of the ASEAN Medical Device Directive (AMDD). The AO establishes the mandatory post-market surveillance framework for medical devices in the Philippines to ensure continued safety, performance and quality following

Philippines: Administrative Order 2025-0030 Implementing Guidelines for the Post-Marketing Alert System (PMAS) Requirements, Annex 5 of the ASEAN Medical Device Directive (AMDD) Read More »

Scroll to Top

Contact Us

Contact Form Demo